Patent · US Active

Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds

US7858756B2 · kind B2 · utility

9Cited by

25References

17Claims

0Family size

Assignee

THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS · US

Inventors

S. Michael Owens · Little Rock, US
Melinda Gunnell · Conway, US
Yingni Chi · Little Rock, US
F. Ivy Carroll · Durham, US
Ralph Henry · Fayetteville, US
Eric C. Peterson · East Longmeadow, US

Key dates

Filing date	Jun 15, 2007
Grant date	Dec 28, 2010
Priority date	—
Expiry date	Oct 17, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention generally relates to monoclonal antibodies that recognize at least one compound from the group consisting of (+) methamphetamine, (+) amphetamine, and (+) 3,4-methylenedioxymethamphetamine ((+) MDMA). Generally speaking, the monoclonal antibodies do not recognize (−) methamphetamine, (−) amphetamine, or (−) MDMA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.